A fully integrated specialty pharmaceutical company with industry-leading transdermal expertise
Launch of SECUADO[r]
Published on February 13, 2020,
by
You are about to leave Noven.com to:
Link Placeholder
Please be advised that Noven has no control over the content or presentation of the site you are about to view. Click the "Continue" button to proceed.
To return to Noven.com, click "Cancel" or close this window.
For U.S. Audience Only
©1999-2025 Noven Pharmaceuticals, Inc.
All rights reserved.